Alaster Allum
Senior Global Medical Affairs Lead, Renal Medicine @AstraZeneca
Signup · Get unlimited contacts
WORK HISTORY
Senior Global Medical Affairs Lead, Renal Medicine @AstraZeneca
Cambridge, GB
Therapeutic Area- Renal medicine: Lokelma and RoxadustatCountries Supported- China, EU, and international regionsOrganisational and People Management roles- Chair of Cross-Functional Communications Working Group- Chair of Global Medical Team (GMT)- Chair and medical lead for cardiology and nephrology Advisory boards- Responsible for medical strategy for heart failure and CKDInnovation and Healthcare Transformation- Cut time to KEE advisory feedback from months to weeks by sourcing and launching virtual advisory board project- Transformed the burden to patients involved in clinical studies by leading the integration of Noom app into phase 4 clinical design and transforming patient data entry- Greatly reduced patient study visit burden by converting all unnecessary site visits to virtual visits - Driver of guideline implementation by leading the development of the global Delphi consensus on hyperkalaemia management. This publication was cascaded globally. Markets saw the value and adopted the methodology publishing local versions- Driver of the strategic vision for Lokelma as more than potassium and including the patient, caregiver and extended healthcare system- Responsible for including cardiologist in nephrology congress speaker panels to cover heart failure in the comorbid patient- Medical lead on first AZ cardiorenal CME event bringing cardiologists and nephrologists together, including establishing a relationship with and inviting the first cardiorenal clinic in UK- Responsible for finding and establishing relationships with cardiologists with experience transforming care for cardiorenal patientsEvidence- Medical lead for CONTINUITY ph4 study the first Lokelma RCT studying transition of care from inpatient to outpatient. Responsible for design, scientific committee selection, protocol amendments, author- medical lead for ZORA RWE programme, author- Congress presenter: US RWE data at ERA (oral)
EDUCATION
University of London
MBBS, Medicine
University of Cambridge
BA, Medical Sciences Tripos
Saïd Business School, University of Oxford
PGDip, Strategy and Innovation
SKILLS
ABOUT ALASTER ALLUM
With two decades in the pharmaceutical industry, I have launched 11 drugs across 8 therapeutic areas, held roles from in-country MSL to Head of Global Medical Affairs, and covered Asia, EU, LATAM and US. I have managed large and small teams locally and globally, and worked in flat cross functional structures. Through successful engagement with regulators and health authorities I have shortened launch timelines and expanded access to drugs under my control. I have a solid track record in evidence generation writing protocols and leading impactful phase 4 studies like CONTINUITY and GRAZE. With an interest in digital opportunities, I have brought innovation to my work, enhancing processes through initiatives like the GreenRoom virtual advisory platform and building digital healthcare into study design. My ability to build strong relationships with experts and academic societies has resulted in enduring collaborations that have impacted business, shaped clinical practice and informed guidelines.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.